Category Archives: mdCurrent Conference Reports

Hormone replacement therapy may increase the risk of ulcerative colitis in postmenopausal women

mdCurrent Conference Report: Digestive Disease Week Hormone replacement therapy (HRT) may increase the risk of ulcerative colitis in postmenopausal women, according to a new study presented at Digestive Disease Week 2012. “It is important that clinicians are aware of the results of this study, but it should not lead to… 

Read more »
Also posted in Gastroenterology, Pharmacology, Primary Care, Women's Health | Tagged , , , , , , , , , , , | Volume: | 1 Response

Early therapy delays progression to clinically definite multiple sclerosis

mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting Data from 2 major phase 3 trials have demonstrated that progression to clinically definite multiple sclerosis (MS) can be prevented or delayed with early rather than delayed therapy. Two regimens of subcutaneous interferon beta-1a (IFNb) were evaluated in patients who… 

Read more »
Also posted in Neurology, Pharmacology | Tagged , , , , , , , , , , | Volume: | Leave a comment

Pacemaker study examines whether Indians age earlier than Westerners

mdCurrent Conference Report: Heart Rhythm 33rd Annual Scientific Sessions Indians presenting for permanent pacemaker (PP) placement are younger than those in the Western population, according to results of a study presented at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS). Key Point: Indians present at a younger… 

Read more »
Also posted in Cardiology, Cardiovascular Disease, Geriatrics, Non-Communicable Disease, Primary Care | Tagged , , , , , , , , | Volume: | 1 Response

Continuous intestinal infusion of levodopa-carbidopa gel shows benefit in advanced Parkinson’s disease

mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting A novel strategy to reduce the motor complications associated with fluctuating blood levels of levodopa in patients with Parkinson’s disease was associated with clinically meaningful improvements in disease control, according to the authors of a double-blind trial. Undertaken in patients… 

Read more »
Also posted in Neurology, Pharmacology | Tagged , , , , , , | Volume: | Leave a comment

First oral disease modifying therapy for multiple sclerosis challenges injectables in long-term data

mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting Follow-up data out to 24 months for the first oral disease modifying therapy (DMT) licensed for treatment of multiple sclerosis (MS) continues to suggest that the efficacy and safety rivals that of the injectable agents that have been the MS… 

Read more »
Also posted in Neurology, Pharmacology | Tagged , , , , , , , | Volume: | Leave a comment

Pregabalin found more effective than pramipexole in restless leg syndrome

mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting A major multicenter study undertaken in restless leg syndrome (RLS) demonstrated greater efficacy for the alpha-2-delta ligand pregabalin than the dopamine agonist pramipexole, which has been widely regarded until now as the first-line treatment. In the study, presented at the… 

Read more »
Also posted in Neurology, Pharmacology, Primary Care | Tagged , , , , , , , , | Volume: | Comments closed
  • Follow mdCurrent Health for the latest health news!

    Email Newsletter